Sigilon Therapeutics Price Prediction
| SGTXDelisted Stock | USD 21.11 0.33 1.54% |
Oversold Vs Overbought
81
Oversold | Overbought |
Using Sigilon Therapeutics hype-based prediction, you can estimate the value of Sigilon Therapeutics from the perspective of Sigilon Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Sigilon Therapeutics to buy its stock at a price that has no basis in reality. In that case, they are not buying Sigilon because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Sigilon Therapeutics after-hype prediction price | USD 21.11 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as delisted stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Sigilon |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Sigilon Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Sigilon Therapeutics After-Hype Price Prediction Density Analysis
As far as predicting the price of Sigilon Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Sigilon Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Sigilon Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Sigilon Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting Sigilon Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Sigilon Therapeutics' historical news coverage. Sigilon Therapeutics' after-hype downside and upside margins for the prediction period are 21.11 and 21.11, respectively. We have considered Sigilon Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Sigilon Therapeutics is very steady at this time. Analysis and calculation of next after-hype price of Sigilon Therapeutics is based on 3 months time horizon.
Sigilon Therapeutics Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Sigilon Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Sigilon Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Delisted Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Sigilon Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.00 | 0.00 | 0.00 | 0.00 | 8 Events / Month | 12 Events / Month | In about 8 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
21.11 | 21.11 | 0.00 |
|
Sigilon Therapeutics Hype Timeline
Sigilon Therapeutics is at this time traded for 21.11. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Sigilon is anticipated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is anticipated to be very small, whereas the daily expected return is at this time at 0.0%. %. The volatility of related hype on Sigilon Therapeutics is about 0.0%, with the expected price after the next announcement by competition of 21.11. About 54.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 0.25. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Sigilon Therapeutics recorded a loss per share of 14.83. The entity had not issued any dividends in recent years. The firm had 1:13 split on the 23rd of May 2023. Given the investment horizon of 90 days the next anticipated press release will be in about 8 days. Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.Sigilon Therapeutics Related Hype Analysis
Having access to credible news sources related to Sigilon Therapeutics' direct competition is more important than ever and may enhance your ability to predict Sigilon Therapeutics' future price movements. Getting to know how Sigilon Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Sigilon Therapeutics may potentially react to the hype associated with one of its peers.
Sigilon Therapeutics Additional Predictive Modules
Most predictive techniques to examine Sigilon price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Sigilon using various technical indicators. When you analyze Sigilon charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Sigilon Therapeutics Predictive Indicators
The successful prediction of Sigilon Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Sigilon Therapeutics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Sigilon Therapeutics based on analysis of Sigilon Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Sigilon Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Sigilon Therapeutics's related companies.
Story Coverage note for Sigilon Therapeutics
The number of cover stories for Sigilon Therapeutics depends on current market conditions and Sigilon Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Sigilon Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Sigilon Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Sigilon Therapeutics Short Properties
Sigilon Therapeutics' future price predictability will typically decrease when Sigilon Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Sigilon Therapeutics often depends not only on the future outlook of the potential Sigilon Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Sigilon Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 32.4 M | |
| Cash And Short Term Investments | 69.6 M |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Other Consideration for investing in Sigilon Stock
If you are still planning to invest in Sigilon Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Sigilon Therapeutics' history and understand the potential risks before investing.
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |